Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Phenylephrine hydrochloride may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for 2. What you need to know before you take Max strength congestion relief capsules 3. How to take Max strength congestion relief capsules 4. Possible side effects 5. How to store Max Strength Congestion Relief capsules 6. Contents of the pack and other information 1. What Max strength congestion relief capsules are and what they are used for Your capsules contain the active ingredient, phenylephrine hydrochloride, a decongestant that reduces swelling in the passages of the nose to help you breathe more easily. Your capsules are used for the relief of nasal congestion, particularly when associated with colds and flu or hayfever.
e Max strength congestion relief capsules Do not take this medicine if you:
these are medicines such as phenelzine and isocarboxazid
This medicine contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Max strength congestion relief capsules
Google Play or Apple App Store. By reporting side affects you can help provide more information on the safety of this medicine.
Warning: Do not exceed the stated dose. Avoid alcohol whilst taking this medicine. If you take too many capsules by mistake, contact your doctor or pharmacist straight away. If symptoms persist or worsen, or if new symptoms occur, consult your doctor or pharmacist.
not listed in this leaflet. You can also report side effects directly via the Yellow This leaflet was last revised in 09/2025. MPLLPHE12.2CP012 Card Scheme at: www.mhra.gov.uk/yellowcard FPLXXX392V01_A GSL or search for MHRA Yellow Card in the
Flamingo Max Strength Congestion Relief 12.2 mg Capsules, Hard
28 mm
Package Leaflet: Information for the user
5 mm
28 mm
140 mm
Back Page
Max strength congestion relief capsules
Keep out of the sight and reach of children. Do not use these capsules after the expiry For oral use, swallow whole with water. date mentioned on the blisters and carton. Adults, the elderly and children 12 years Do not store above 25°C. Store in the original and over : 1 capsule every 6 hours, as required. packaging to protect from moisture. Do not take more than 4 capsules in any 24 Do not throw away any medicines via hour period. wastewater or household waste. Not recommended for children under 12 Ask your pharmacist how to throw away years of age. Do not take for longer than 7 days unless you medicines you no longer use. These measures will help protect the environment. have been advised to do so by your doctor.
4. Possible side effects
Each capsule contains 12.2mg of Phenylephrine Hydrochloride. The other ingredients are lactose monohydrate maize starch, pregelatinised starch, magnesium stearate. Capsule shells are made of gelatin, iron oxide yellow and sodium laurilsulfate. What Max strength congestion relief capsules looks like and contents of the pack Size "3" hard gelatin capsule, yellow translucent cap & body, containing white to off-white granular powder or powder plug.
Most people do not have any side effects while taking this medicine. However, if you experience any of the following side effects, or anything else unusual happens, stop taking the medicine immediately and see your doctor Max strength congestion relief capsules are or pharmacist. available in cartons containing AluminiumPVC/PVDC White Opaque Film blister packs Possible side effects are: of 12 Capsules.
Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard comes as capsule containing 12.2mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard is phenylephrine hydrochloride.
This leaflet reproduces the patient information leaflet approved for Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the relief of nasal congestion, particularly when associated with colds and flu or hayfever.
Adults and children 12 years and over: For oral use, one capsule, if necessary, up to four times daily.
The Elderly: Normal adult dosage is appropriate.
Children under 12 years: Not recommended.
Hypersensitivity to any of the ingredients. Avoid in patients with cardiovascular disease, hypertension, diabetes mellitus, closed angle glaucoma, hyperthyroidism, prostatic enlargement and phaeochromocytoma. Patients being treated with monoamine oxidase inhibitors or within 14 days of ceasing such treatment (see section 4.5).
This medicine should be used with caution in patients with occlusive vascular disease including Raynaud's phenomenon. Do not take for longer than 7 days, unless your doctor agrees.
This medicine contains 40.3 mg Lactose Monohydrate. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
If symptoms do not go away seek a doctor's advice.
Use with caution in patients with Raynaud's phenomenon and diabetes mellitus.
Patients with prostatic hypertrophy may have increased difficulty with micturition.
Sympathomimetic-containing products should be used with great care in patients suffering from angina.
Sympathomimetic-containing products may act as cerebral stimulants giving rise to insomnia, nervousness, and hyperpyrexia, tremor and epileptiform convulsions.
Should not be given to patients being treated with monoamine oxidase inhibitors or within 14 days of stopping such treatment. May enhance the effects of anticholinergic drugs such as tricyclic antidepressants. May increase the possibility of arrhythmias in digitalised patients. May enhance the cardiovascular effects of other sympathomimetic amines (e.g. decongestants). This medicine should not be taken together with vasodilators, Beta-blockers or enzyme inducers such as alcohol.
The safety of this medicine during pregnancy and lactation has not been established but in view of a possible association of foetal abnormalities with first trimester exposure to phenylephrine, the use of the product during pregnancy should be avoided. In addition, because phenylephrine may reduce placental perfusion, the product should not be used in patients with a history of pre-eclampsia. In view of the lack of data on the use of phenylephrine during lactation, this medicine should not be used during breast feeding
No adverse effects known.
Adverse effects may include tachycardia, cardiac arrhythmias, palpitations, hypertension, nausea, vomiting and headache. Urinary retention - this is more likely to occur in men with an enlarged prostate' (frequency not known).
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Symptoms of over dosage include irritability, restlessness, palpitations, hypertension, and difficulty in micturition, nausea, vomiting, thirst and convulsions. In severe over dosage gastric lavage and aspiration should be performed. Symptomatic and supportive measures should be undertaken, particularly with regard to cardiovascular and respiratory systems. Convulsions should be controlled with intravenous diazepam. Chlorpromazine may be used to control marked excitement and hallucinations. Severe hypertension may need to be treated with an alpha-adrenoreceptor blocking drug, such as phentolamine. A beta blocker may be required to control cardiac arrhythmias.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.